FIS VS 150 C Component A (Mortar)

Hazard statements (CLP)

H315, H317, H318

Code

Statements

H315

Causes skin irritation

SECTION 2: Hazards identification

Hazard statements

see section 16 : H315 - Causes skin irritation. H317 - May cause an allergic skin reaction. H318 - Causes serious eye damage.

Adverse physicochemical, human health and environmental effects

Causes skin irritation. May cause an allergic skin reaction. Causes serious eye damage.

2.2 Label elements

Labelling

Hazard pictograms

GHS05 GHS07

Signal word

Danger

Contains

1,4-butanediol dimethacrylate; Hydroxypropyl methacrylate; portland cement

Precautionary statements

P101 - If medical advice is needed, have product container or label at hand. P102 - Keep out of reach of children. P280 - Wear protective gloves, protective clothing/eye protection/face protection. P305+P351+P338 - IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continue rinsing. P310 - Immediately call a POISON CENTER or doctor.

2.3 Other hazards

Contains no PBT/vPvB substances ≥ 0.1% assessed in accordance with REACH Annex XIII C o m p o n e n t 1,4-butanediol dimethacrylate (2082-81-7) This substance/mixture does not meet the PBT criteria of REACH regulation, annex XIII This substance/mixture does not meet the vPvB criteria of REACH regulation, annex XIII Hydroxypropyl methacrylate (27813-02-1) This substance/mixture does not meet the PBT criteria of REACH regulation, annex XIII This substance/mixture does not meet the vPvB criteria of REACH regulation, annex XIII portland cement (65997-15-1) This substance/mixture does not meet the PBT criteria of REACH regulation, annex XIII This substance/mixture does not meet the vPvB criteria of REACH regulation, annex XIII The mixture does not contain substance(s) included in the list established in accordance with Article 59(1) of REACH for having endocrine disrupting properties, or is not identified as having endocrine disrupting properties in accordance with the criteria set out in Commission Delegated Regulation (EU) 2017/2100 or Commission Regulation (EU) 2018/605 at a concentration equal to or greater than 0,1 %